SenzaGen AB
SENZA
Rank in Stocks
#27209
SenzaGen AB specializes in pioneering, conducting, and commercializing... SenzaGen AB specializes in pioneering, conducting, and commercializing animal-free methods to evaluate the allergic potential of various substances. Their product portfolio encompasses several in vitro tests: GARDskin identifies potential chemical skin sensitizers; GARDpotency, an enhancement to GARDskin, categorizes their strength; GARDskin Dose-response delivers precise quantitative assessment of skin sensitizing potency; and GARDair detects chemical respiratory sensitizers. They also offer GARDskin medical device for assessing skin sensitization caused by medical equipment and solid materials. Furthermore, the company provides services for irritation and corrosion analysis. SenzaGen distributes its solutions through a network of licensed partners and distributors. The firm also collaborates with the Research Institute for Fragrance Materials to develop novel photosensitization tests. Founded in 2010, the company's headquarters are located in Lund, Sweden.
Share Price
$0.49482678
Last synced: 2026-11-09
Market Cap
$16.09M
Change (1 day)
-1.12%
Change (1 year)
-27.16%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade SenzaGen AB (SENZA)
Category
Healthcare
EPS for SenzaGen AB (SENZA)
EPS as of June 2026 TTM: $-0.04
According to SenzaGen AB's latest financial reports, its current EPS (TTM) is $-0.04. At the end of 2025 the company had an EPS of $-0.04, an increase over its 2024 EPS of $-0.06.
EPS history for SenzaGen AB from 2014 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.04 | -11.75% |
| 2025 | $-0.04 | -28.18% |
| 2024 | $-0.06 | -34.70% |
| 2023 | $-0.09 | -8.70% |
| 2022 | $-0.10 | -31.20% |
| 2021 | $-0.14 | -7.30% |
| 2020 | $-0.15 | -53.51% |
| 2019 | $-0.33 | 186.25% |
| 2018 | $-0.12 | -3.88% |
| 2017 | $-0.12 | 32.49% |
| 2016 | $-0.09 | 196.75% |
| 2015 | $-0.03 | -1,126.67% |
| 2014 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $18.99 | -53,896.03% |
US
|
|
| $6.12 | -17,437.11% |
US
|
|
| $1.38 | -4,001.13% |
CN
|
|
| $14.83 | -42,111.33% |
US
|
|
| $5.09 | -14,519.26% |
US
|
Questions about SenzaGen AB's earnings per share (EPS)
What is SenzaGen AB's earnings per share (EPS)?
SenzaGen AB's earnings per share (EPS) over the last twelve months is $-0.04, as of Jun 2026.
What was SenzaGen AB's earnings per share (EPS) in 2025?
In 2025, SenzaGen AB's earnings per share (EPS) was $-0.04, compared with $-0.06 in 2024.
How has SenzaGen AB's earnings per share (EPS) changed since 2020?
From 2020 to 2025, SenzaGen AB's earnings per share (EPS) was highest in 2025 ($-0.04) and lowest in 2020 ($-0.15).
How does SenzaGen AB's earnings per share (EPS) compare with similar companies?
SenzaGen AB's earnings per share (EPS) ($-0.04) is lower than that of all 5 similar companies listed above. The highest among them is Thermo Fisher Scientific Inc., with $18.99.